Anthony Miniaci, MD
Orthopaedic Surgery · Cleveland, OHNPI 1407891781
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,994,253 of the $3,126,424 with a category attached, or 63.8%. Anika Therapeutics, Inc. accounts for 71.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $941,572 and has fallen 73.4% since, to $250,802 in 2025. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 463 payments — averaging $6752.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$2.2M
- Arthrosurface Incorporated$884K
- Arthrex$6K
- Stryker$1K
- Amniox Medical, Inc.$786
- Exactech, Inc.$467
- plus $2K from 12 others
What the payments were for
- Royalty or licence$1,994,25364%
- Consulting fees$269,2099%
- Speaking & faculty fees$59,1002%
- Travel & lodging$26,7911%
- Food & beverage$10,7600%
- Education$4,0320%
- Ownership interest$636,19320%
- Other$126,0854%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 217 | $2,232,798 |
| Arthrosurface Incorporated | 158 | $883,628 |
| Arthrex | 54 | $6,163 |
| Stryker | 10 | $1,026 |
| Amniox Medical, Inc. | 1 | $786 |
| Exactech, Inc. | 3 | $467 |
| Zimmer Biomet | 4 | $339 |
| Shoulder Innovations, Inc. | 1 | $332 |
| Smith+Nephew | 3 | $203 |
| Johnson & Johnson(2 entities) | 4 | $192 |
| Trice Medical, Inc. | 1 | $154 |
| Catalyst Orthoscience | 1 | $128 |
| DJO, LLC | 1 | $86 |
| Integra Lifesciences Corporation | 1 | $45 |
| Rock Medical Orthopedics, Inc. | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $22 |
| Bioventus LLC | 1 | $16 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP Shoulder$589,042
- OVO Motion$551,737
- RevoMotion$433,776
- GlenoJet$398,964
- OVOMotion$377,203
- WAVEKAHUNA$246,489
- UNICAP$246,489
- HemiCAP Patella-Femoral XL$122,563
- HemiCAP Patella-Femoral$82,839
- GLENOJET ALLOGRAFT$59,082
- PFXL$58,903
- SHOULDER IMPLANT$42,949
- TACTOSET$26,532
- OVO$22,705
- Inlay Glenoid 2.0$19,851
- UniCAP Resurfacing System$9,492
- WristMotion$9,100
- PF Kahuna$8,370
- HemiCAP$7,552
- AlignMATE$7,539
How this compares
$3,126,424 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $9,737 |
| JanuviaSitagliptin Phosphate | 19 | $7,249 |
| JanumetSitagliptin Phos/Metformin Hcl | 18 | $3,632 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $1,840 |
| Atorvastatin Calcium | 96 | $1,017 |
| Famotidine | 27 | $963 |
| Entacapone | 12 | $874 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 26 | $710 |
| CholestyramineCholestyramine (With Sugar) | 11 | $695 |
| Memantine Hcl | 22 | $630 |
| Icosapent Ethyl | 12 | $600 |
| Metoprolol Succinate | 34 | $464 |
| RivastigmineRivastigmine Tartrate | 19 | $441 |
| Hydroxyzine Hcl | 24 | $350 |
| Digoxin | 29 | $302 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Cleveland
- Reuben GobezieCleveland$12M
- Wael BarsoumCleveland$8.9M
- Joseph IannottiCleveland$7.1M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
- Robert MolloyCleveland$2.3M
- Eric RicchettiCleveland$2.1M
- Thomas MrozCleveland$1.3M
- Robert GillespieCleveland$672K
- George ThompsonCleveland$420K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.